[Antibacterial activity, pharmacokinetics and clinical use of a new cephalosporin antibiotic cephacetrile].
D000081:Acetamides / Q000378:metabolism / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000898:Antibiosis; D001646:Bile / Q000378:metabolism; D002511:Cephalosporins / Q000378:metabolism* / Q000627:therapeutic use; D003404:Creatinine / Q000378:metabolism; D004341:Drug Evaluation; D004886:Erysipelas / Q000188:drug therapy; D005260:Female; D006207:Half-Life; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007668:Kidney / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000378:metabolism; D007677:Kidney Function Tests; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009570:Nitriles / Q000378:metabolism / Q000627:therapeutic use; D011704:Pyelonephritis / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy
D000081:Acetamides; D002511:Cephalosporins; D009570:Nitriles; D003404:Creatinine
Activité antibacterienne, pharmacocinétique et utilisation clinique d'un nouvel antibiotique céphalosporanique, la céphacétrile